0000899243-20-009409.txt : 20200325 0000899243-20-009409.hdr.sgml : 20200325 20200325170021 ACCESSION NUMBER: 0000899243-20-009409 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200323 FILED AS OF DATE: 20200325 DATE AS OF CHANGE: 20200325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robinson James A. Jr. CENTRAL INDEX KEY: 0001734295 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38667 FILM NUMBER: 20742923 MAIL ADDRESS: STREET 1: 852 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Urovant Sciences Ltd. CENTRAL INDEX KEY: 0001740547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 5281 CALIFORNIA AVENUE STREET 2: SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 BUSINESS PHONE: 949-226-6029 MAIL ADDRESS: STREET 1: 5281 CALIFORNIA AVENUE STREET 2: SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-23 0 0001740547 Urovant Sciences Ltd. UROV 0001734295 Robinson James A. Jr. C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVENUE, SUITE 100 IRVINE CA 92617 1 1 0 0 PEO;CEO/Urovant Sciences, Inc. Stock Appreciation Right (Right to Buy) 9.16 2020-03-23 4 A 0 845732 0.00 A 2030-03-22 Common Shares 845732 845732 D 25% of the stock appreciation rights ("SARs") shall vest and become exercisable on March 23, 2021; the remaining SARs vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date. The SARs may be settled in cash or in the Issuer's common shares. /s/ Bryan Smith, Attorney-in-Fact 2020-03-25